P1.02-03 the Role of Lung Cancer Advocacy Organizations in Biomarker Testing

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.673
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.02-09 Identifying Gaps in Messaging for Biomarker Testing in the Lung Cancer Community: Need for Consistent and Actionable Messaging

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.02-07 the Role of Volunteers in Quality Palliative Care Delivery for Advance Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immunocytochemistry for Predictive Biomarker Testing in Lung Cancer Cytology

Cancer cytopathology
Cancer ResearchOncology
2019English

Updates Regarding Biomarker Testing for Non–Small Cell Lung Cancer: Considerations From the National Lung Cancer Roundtable

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P1.02-08 Hope for People Living With Metastatic Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.02-05 ALK Positive Lung Cancer: Patient Engagement and Partnership

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Biomarker Testing in Non-Small Cell Lung Cancer: To Move Forward With Quality

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2012English

P3.09-03 Alteration of Gut Microbiome in Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Non–small Cell Lung Cancer Predictive Biomarker Testing via Immunocytochemistry: Ways of Future Past?

Cancer cytopathology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy